Generation of Multivalent Nanobody-Based Proteins with Improved Neutralization of Long α-Neurotoxins from Elapid Snakes
Authors:
- Jack WadeJWJack Wade
- Charlotte RimbaultCRCharlotte Rimbault
- Hanif AliHAHanif Ali
- Line LedsgaardLLLine Ledsgaard
- Esperanza Rivera-De-TorreEsperanza Rivera-De-Torre
- Maher Abou HachemMHMaher Abou Hachem
- Kim BoddumKBKim Boddum
- Nadia MirzaNMNadia Mirza
- Markus-Frederik BohnMBMarkus-Frederik Bohn
- Siri A. SakyaSSSiri A. Sakya
- Fulgencio Ruso-JulveFRFulgencio Ruso-Julve
- Jan Terje AndersenJAJan Terje Andersen
Open Access
- 23 July 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 33 (8) , 1494-1504
Abstract
Recombinantly produced biotherapeutics hold promise for improving the current standard of care for snakebite envenoming over conventional serotherapy. Nanobodies have performed well in the clinic, and in the context of antivenom, they have shown the ability to neutralize long α-neurotoxins in vivo. Here, we showcase a protein engineering approach to increase the valence and hydrodynamic size of neutralizing nanobodies raised against a long α-neurotoxin (α-cobratoxin) from the venom of the monocled cobraNaja kaouthia. Based on the p53 tetramerization domain, a panel of anti-α-cobratoxin nanobody-p53 fusion proteins, termed Quads, were produced with different valences, inclusion or exclusion of Fc regions for endosomal recycling purposes, hydrodynamic sizes, and spatial arrangements, comprising up to 16 binding sites. Measurements of binding affinity and stoichiometry showed that the nanobody binding affinity was retained when incorporated into the Quad scaffold, and all nanobody domains were accessible for toxin binding, subsequently displaying increased blocking potency in vitro compared to the monomeric format. Moreover, functional assessment using automated patch-clamp assays demonstrated that the nanobody and Quads displayed neutralizing effects against long α-neurotoxins from both N. kaouthia and the forest cobra N. melanoleuca. This engineering approach offers a means of altering the valence, endosomal recyclability, and hydrodynamic size of existing nanobody-based therapeutics in a simple plug-and-play fashion and can thus serve as a technology for researchers tailoring therapeutic properties for improved neutralization of soluble targets such as snake toxins.Keywords
Funding Information
- Norges Forskningsr?d (287927, 314909)
- Villum Fonden (00025302)
- Carlsbergfondet (2011-01-0598)
- H2020 European Research Council (850974)
This publication has 37 references indexed in Scilit:
- Challenges to production of antibodies in bacteria and yeastJournal of Bioscience and Bioengineering, 2015
- Targeting FcRn for the modulation of antibody dynamicsMolecular Immunology, 2015
- Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector FunctionsThe Journal of Immunology, 2015
- High yield purification of nanobodies from the periplasm of E. coli as fusions with the maltose binding proteinProtein Expression and Purification, 2013
- Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubulesMolecular Biology of the Cell, 2013
- In Vivo Neutralization of α-Cobratoxin with High-Affinity Llama Single-Domain Antibodies (VHHs) and a VHH-Fc AntibodyPLOS ONE, 2013
- Ligand-binding domain of an α7-nicotinic receptor chimera and its complex with agonistNature Neuroscience, 2011
- Snakebite envenoming from a global perspective: Towards an integrated approachToxicon, 2010
- Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)Journal of Biological Chemistry, 2006
- Macromolecules released from polymers: diffusion into unstirred fluidsBiomaterials, 1990